Antitumor Effects of Dihydromyricetin and Bevacizumab on SKOV-3 Ovarian Cancer Cell Line Post published:July 7, 2022 Post category:Sarcouncil Journal of Internal Medicine and Public Health Vol-1 Issue-3 Post author:Ozlem Ozgur Gursoy, M.D, Hulusi Goktug Gurer, M.D, Ceren Yildiz ErenM.D, Ayşe Tansu Koparal Professor, Sinem Dabağoğlu Continue ReadingAntitumor Effects of Dihydromyricetin and Bevacizumab on SKOV-3 Ovarian Cancer Cell Line